
The FDA is allowing the pen to be used for the treatment of atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis (CRSwNP) patients at least 12 years old.
Kenny Walter is an editor with HCPLive. Prior to joining MJH Life Sciences in 2019, he worked as a digital reporter covering nanotechnology, life sciences, material science and more with R&D Magazine. He graduated with a degree in journalism from Temple University in 2008 and began his career as a local reporter for a chain of weekly newspapers based on the Jersey shore. When not working, he enjoys going to the beach and enjoying the shore in the summer and watching North Carolina Tar Heel basketball in the winter.

The FDA is allowing the pen to be used for the treatment of atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis (CRSwNP) patients at least 12 years old.

Individuals at 15 years old with depression experience struggles with both sleep patterns and sleep quality.

ADHD symptoms are highly comorbid with insomnia, restless leg syndrome, and snoring.

Antipsychotics commonly cause a number of side effects including weight gain and long-term cardiovascular disease.

Cardiovascular events and death increased by 20% in people with 4 or more depressive symptoms compared to individuals without depressive symptoms.

During the induction period, patients in the treatment group had higher incidences of infections and serious infectious compared to placebo.

In multiple clinical trials, investigators do not find any serious adverse events.

Association with familial history found in hospitalizations, suicide attempts, and an earlier onset of symptoms.

Lower treatment odds for women were also observed in a set of 7 studies that had data on the subgroup of patients eligible for IV rtPA treatment.

Time of cannabis use can predict larger decreases in intrusions and irritability in individuals suffering from PTSD.

Between 2002-2019, NASH is the leading liver indication for women without HCC.

New recommendations support the use of probiotics for preterm and low birthweight infants to prevent mortality and necrotizing enterocolitis.

High-potency cannabis use led to an increase in cannabis use frequency, as well as cannabis problems.

Investigators expect an increase in demand for mental health services for young people in the coming years.

In recent years, ustekinumab and tofacitinib have both been effective in treating ulcerative colitis.

More prospective studies are needed to examine how different drugs can be effective for schizophrenia patients based on the cluster of symptoms.

Antipsychotic discontinuation remains a major hurdle for effective schizophrenia treatment.

Currently, the use of minocycline is limited orally due to some systemic side effects.

The results of a phase 3B study show the medication is effective treating the disorder despite only needing to be taken once every 8 weeks.

Researchers are continuing to learn how the COVID-19 virus will effect patients with inflammatory bowel disease.

In a new study, investigators discover insomnia severity could predict first-onset major depressive disorder.

In an international survey, investigators discover women are more likely to suffer from a FGID than men.

In the latest edition of the DocTalk Podcast, Dr. Mark Smith talks about some of the issues related to the COVID-19 lockdown and how a second wave might psychologically impact individuals.

Older age and higher educational level were associated with only the conditional probability of an individual treatment professional being perceived as helpful.

Investigators estimate 40-50% of proton pump inhibitor users are using inappropriately.

Investigators find a greater increase in positive symptoms after a ketamine infusion when compared to placebo.

Asthmatic infants often suffer from other comorbidities throughout their lives.

In an abstract presenting during the ATS conference, investigators find infants with asthma are surprisingly older on the epigentic clock.

Obstructive sleep apnea can be linked to the development of non-alcoholic fatty liver disease.

In a new study presented at ATS, investigators find CPAP withdrawal worsens the augmentation index.